YF Life Launches CritiCare Continuation Insurance Plan Series

Bridging the Critical Illness Protection Gap for a Worry-Free Future

August 18, 2025

​​YF Life Insurance International Ltd. (YF Life) is pleased to announce the launch of its new “CritiCare Continuation Insurance Plan Series”. This innovative series is specially designed for individuals who have a history of designated illnesses, such as heart disease, stroke, cancer or diabetes. These plans are created to address the significant challenges that such individuals¹ often encounter when applying for critical illness insurance plans, including higher loading imposed or even being declined, due to their medical history, and to help close the critical illness protection gap.

The “CritiCare Continuation Insurance Plan Series” is a series of participating plans offering critical illness protection which eliminate traditional barriers by offering a simplified underwriting process with no medical examination required at the time of application. It consists of “CritiCare Continuation Cardio Insurance Plan”, “CritiCare Continuation Cancer Insurance Plan” and “CritiCare Continuation Diabetes Insurance Plan”. These plans provide coverage for up to 149 critical illnesses², including a wide range of major critical Illnesses, early stage diseases as well as carcinoma-in-situ / early stage cancers. They offer guaranteed lifetime renewability up to age 100³, ensuring long-term protection for customers’ health. The total benefit payout can reach up to 170% of the basic sum insured⁴, which includes Peace of Mind Protection such as Cancer Income Benefit, Experimental Drugs Benefit⁵, and Mental Incapacity Advance Instruction Option.

The launch of “CritiCare Continuation Insurance Plan Series” embodies YF Life’s commitment to creating innovative solutions that meet the unique market needs of its customers. By leveraging product innovation, the company aims to deliver thoughtful protection that empowers customers to face the future with confidence, regardless of their health history.

To celebrate the launch, YF Life is offering a total discount equivalent to 10% of the first-year’s premium⁶ for all successful applicants who meet the specified requirements. This limited-time offer is valid until September 30, 2025.

For more details on the “CritiCare Continuation Insurance Plan Series” and the promotional offer, please visit www.yflife.com.

Remark: 

1. Eligibility for application and underwriting varies by insurance plan. For details, please contact a financial consultant for more information.

2. Applicable only to the CritiCare Continuation Cancer Insurance Plan and the CritiCare Continuation Diabetes Insurance Plan​​. The CritiCare Continuation Cardio Insurance Plan​​ provides coverage for 78 critical illnesses.

3. Applicable only to specified critical illnesses.

4. Applicable only if the Insured is unfortunately diagnosed with Cancer, including: a Critical Illness Benefit of up to 100% of the basic sum insured, a Cancer Income Benefit of up to 50% of the basic sum insured, and an Experimental Drugs Benefit of up to 20% of the basic sum insured.

5. Medical expenses for the experimental drug will be reimbursed based on actual expenses incurred. Please refer to the product brochure for details.

6. Subject to relevant terms and conditions. Please refer to the relevant promotional materials.

The information contained in this press release is intended as a general summary of information for reference only. It shall not be constructed as an offer to sell any product. The above does not contain the full terms and conditions of the relevant insurance plan. For full terms and conditions, details and risk disclosures of the relevant insurance plan, please refer to relevant product brochures, promotion leaflets, and policy documents. In the event of any conflict or inconsistency between the contents of the above information and the relevant policy contracts, the relevant policy contract shall prevail. Although care is taken in preparing the above information, YF Life disclaims any express or implied warranty as to the accuracy of the content and any liability with respect to it.

This press release is intended for distribution in Hong Kong and Macau only and should not be construed as an offer or solicitation to sell or promote any YF Life products outside Hong Kong and Macau. YF Life declares that it has no intention to offer to sell, to solicit to buy or to provide any of its products in any jurisdiction other than Hong Kong and Macau in which such offer to sell or solicitation to buy or provision of any product of YF Life is illegal under the laws of that jurisdiction.